Clinical Trial Update: To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating SHR0302 tablet for efficacy and safety in active psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• SHR0302 (SHR0302)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Psoriatic Arthritis | Phase 3 | Status: UNKNOWN